Prognostic parameters on baseline and interim [18F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients

被引:0
|
作者
Czibor, Sandor [1 ]
Carr, Robert [2 ]
Redondo, Francisca [3 ]
Auewarakul, Chirayu U. [4 ]
Cerci, Juliano J. [5 ]
Paez, Diana [6 ]
Fanti, Stefano [7 ]
Gyorke, Tamas [1 ]
机构
[1] Semmelweis Univ, Med Imaging Ctr, Dept Nucl Med, Budapest, Hungary
[2] Kings Coll London, Guys & St Thomas Hosp, Dept Hematol, London, England
[3] Fdn Arturo Lopez Perez, Oncol Clin, Santiago, Chile
[4] Chulabhorn Royal Acad, HRH Princess Chulabhorn Coll Med Sci, Fac Med & Publ Hlth, Bangkok, Thailand
[5] PET CT Dept Quanta Diagnost & Terapia, Curitiba, Brazil
[6] IAEA, Dept Nucl Sci & Applicat, Div Human Hlth, Nucl Med & Diagnost Imaging Sect, Vienna, Austria
[7] Univ Bologna, Policlin S Orsola, Metropolitan Nucl Med, Bologna, Italy
关键词
diffuse large B-cell lymphoma; Deauville score; PET; metabolic tumor volume; ratio PET; METABOLIC TUMOR VOLUME; PROGRESSION-FREE SURVIVAL; HODGKIN-LYMPHOMA; RESPONSE ASSESSMENT; FDG-PET/CT; PREDICTION; CRITERIA; IPI;
D O I
10.1097/MNM.0000000000001664
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective2-[F-18]fluoro-2-deoxy-d-glucose PET/computed tomography ([F-18]FDG-PET/CT) is a widely used imaging method in the management of diffuse large B-cell lymphomas (DLBCL). Our aim was to investigate the prognostic performance of different PET biomarkers in a multicenter setting. MethodsWe investigated baseline volumetric values [metabolic tumor volume (MTV) and total lesion glycolysis (TLG), also normalized for body weight] segmented with three different methods [>SUV4 (glob4); 41% isocontour (41pc), and a gradient-based lesion growing algorithm (grad)] and interim parameters [Deauville score, maximal standardized uptake value (Delta SUVmax), modified qPET, and ratio PET (rPET)] alongside clinical parameters (stage, revised International Prognostic Index), using 24-month progression-free survival as the clinical endpoint. Receiver operating characteristics analyses were performed to define optimal cutoff points for the continuous PET parameters. ResultsA total of 107 diffuse large B-cell lymphoma patients were included (54 women; mean age: 53.7 years). MTV and TLG calculations showed good correlation among glob4, 41pc, and grad methods; however, optimal cutoff points were markedly different.Significantly different PFS was observed between low- and high-risk groups according to baseline MTV, body weight-adjusted (bwa) MTV, TLG, bwaTLG, as well as interim parameters Deauville score, Delta SUVmax, mqPET, and rPET. Univariate Cox regression analyses showed hazard ratios (HRs) lowest for bwaMTVglob4 (HR = 2.3) and highest for rPET (HR = 9.09). In a multivariate Cox-regression model, rPET was shown to be an independent predictor of PFS (P = 0.041; HR = 9.15). Combined analysis showed that Delta SUVmax positive patients with high MTV formed a group with distinctly poor PFS (35.3%). ConclusionBaseline MTV and TLG values and optimal cutoff points achieved with different segmentation methods varied markedly and showed a limited prognostic impact. Interim PET/CT parameters provided more accurate prognostic information with semiquantitative 'Deauville-like' parameters performing best in the present study.
引用
收藏
页码:291 / 301
页数:11
相关论文
共 50 条
  • [1] Interim 18f[FDG] Positron Emission Tomography in Patients with Diffuse Large B-Cell Lymphoma.
    Gigli, Federica
    Nassi, Luca
    Negri, Mara
    Travaini, Laura
    Steffanoni, Sara
    Liptrott, Sarah Jane
    Mancuso, Patrizia
    Bertazzoni, Paola
    Bassi, Simona
    Calabrese, Liliana
    Cocorocchio, Emilia
    Martinelli, Giovanni
    [J]. BLOOD, 2008, 112 (11) : 1234 - 1234
  • [2] Interim FDG-PET/CT as a prognostic factor in diffuse large B-cell lymphoma
    Fuertes, S.
    Setoain, X.
    Lopez-Guillermo, A.
    Duch, J.
    Paredes, P.
    Pons, F.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S373 - S373
  • [3] Seriously overestimated prognostic value of baseline and interim FDG-PET in diffuse large B cell lymphoma
    Adams, Hugo J. A.
    Kwee, Thomas C.
    [J]. ANNALS OF HEMATOLOGY, 2016, 95 (08) : 1367 - 1368
  • [4] Seriously overestimated prognostic value of baseline and interim FDG-PET in diffuse large B cell lymphoma
    Hugo J. A. Adams
    Thomas C. Kwee
    [J]. Annals of Hematology, 2016, 95 : 1367 - 1368
  • [5] [18F]-FDG PET radiomic model as prognostic biomarker in diffuse large B-cell lymphoma
    Travaini, Laura Lavinia
    Botta, Francesca
    Derenzini, Enrico
    Lo Presti, Giuliana
    Ferrari, Mahila Esmeralda
    Farulla, Lighea Simona Airo
    Radice, Tommaso
    Mazzara, Saveria
    Tarella, Corrado
    Pileri, Stefano
    Raimondi, Sara
    Ceci, Francesco
    [J]. HEMATOLOGICAL ONCOLOGY, 2023, 41 (04) : 674 - 682
  • [6] Prognostic value of interim 18F-FDG PET/CT in diffuse large B-cell lymphoma
    Zhitao Ying
    Xuejuan Wang
    Yuqin Song
    Wen Zheng
    Xiaopei Wang
    Yan Xie
    Ningjing Lin
    Meifeng Tu
    Lingyan Ping
    Weiping Liu
    Lijuan Deng
    Chen Zhang
    Zhi Yang
    Jun Zhu
    [J]. Chinese Journal of Cancer Research, 2013, 25 (01) : 95 - 101
  • [7] Prognostic value of interim 18F-FDG PET/CT in diffuse large B-cell lymphoma
    Ying, Zhitao
    Wang, Xuejuan
    Song, Yuqin
    Zheng, Wen
    Wang, Xiaopei
    Xie, Yan
    Lin, Ningjing
    Tu, Meifeng
    Ping, Lingyan
    Liu, Weiping
    Deng, Lijuan
    Zhang, Chen
    Yang, Zhi
    Zhu, Jun
    [J]. CHINESE JOURNAL OF CANCER RESEARCH, 2013, 25 (01) : 95 - 101
  • [8] Prognostic Value of Baseline Radiomic Features of 18F-FDG PET in Patients with Diffuse Large B-Cell Lymphoma
    Lue, Kun-Han
    Wu, Yi-Feng
    Lin, Hsin-Hon
    Hsieh, Tsung-Cheng
    Liu, Shu-Hsin
    Chan, Sheng-Chieh
    Chen, Yu-Hung
    [J]. DIAGNOSTICS, 2021, 11 (01)
  • [9] POSITIVE INTERIM 18F[FDG] POSITRON EMISSION TOMOGRAPHY SEEMS NOT TO PREDICT RELAPSE IN PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA
    Gigli, F.
    Gardellini, A.
    Bertazzoni, P.
    Travaini, L.
    Negri, M.
    Nassi, L.
    Preda, L.
    Martinelli, G.
    [J]. ANNALS OF ONCOLOGY, 2011, 22 : 158 - 158
  • [10] Interim 18F-FDG PET in Diffuse Large B-Cell Lymphoma: Emerging Worldwide?
    Jamar, Francois
    Lhommel, Renaud
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2015, 56 (05) : 655 - 656